Brief

On June 30, July 24, and August 4, the Justice Department's Antitrust Division, FTC, Commerce, and Health and Human Services will host listening sessions to discuss ways to make prescription drugs more affordable by promoting competition. The sessions will focus on increasing generic and biosimilar availability, promoting competition through drug formularies and benefits, and eliminating regulatory barriers and anticompetitive practices.

This content is restricted.

Highlights content goes here...

This content is restricted.

US Department of Justice (Antitrust Division)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies